-
Catalent Acquires New Biologics Facility
contractpharma
September 27, 2020
Catalent, a global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, has acquired a new manufacturing facility in Bloomington, IN ...
-
Aphena Pharma Invests $21M in Tennessee Expansion
contractpharma
September 23, 2020
Adds 258,000 sq.-ft. to current Cookeville footprint and represents expansion into biologics, cold chain storage and third-party logistics distribution.
-
Thermo Fisher Scientific Opens New Bioprocessing Collaboration Center in St. Louis
americanpharmaceuticalreview
September 15, 2020
Thermo Fisher Scientific has announced the opening of its new Bioprocessing Collaboration Center (BCC) in St. Louis, Missouri.
-
HJB and Ansun Biopharma Enter Biologics Collaboration
contractpharma
September 02, 2020
CMC development and manufacturing partnership expecting to submit an IND application in 2021.
-
CPI Partners with Perceptive Engineering and FujiFilm Diosynth Biotechnologies
contractpharma
August 14, 2020
CPI, an independent technology innovation center, is partnering with Perceptive Engineering and FujiFilm Diosynth Biotechnologies.
-
Wacker Invests in Amsterdam Site
contractpharma
July 30, 2020
Wacker, the Munich-based chemicals group, is investing in its production facilities for biologics, LMPs (live microbial products) and vaccines at its Amsterdam site.
-
Catalent Expands Clinical Manufacturing Operations
contractpharma
July 22, 2020
Invests $30 million to create European clinical manufacturing center of excellence in Limoges, France.
-
Bionova Begins Construction of New Manufacturing Center
contractpharma
July 15, 2020
The 36,000 sq. ft. facility will be located within the company’s headquarters.
-
PCI Pharma Services Completes Biotech CoE
contractpharma
July 01, 2020
PCI is also investing to expand its global packaging capabilities for biologics at its operations in Ireland.
-
ChemPartner Expands Biologics Capabilities
contractpharma
June 17, 2020
Makes additional investments in biologics from research to manufacturing capabilities.